Literature DB >> 9491812

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

G Spurlock1, A Heils, P Holmans, J Williams, U M D'Souza, A Cardno, K C Murphy, L Jones, P R Buckland, P McGuffin, K P Lesch, M J Owen.   

Abstract

Several studies have shown an association between schizophrenia and the C allele of a T-C polymorphism at nucleotide 102 and the 5HT2A receptor gene. In the present study we observed this association in a sample of 63 parent/offspring trios where the proband received a diagnosis of DSM-III-R schizophrenia using TDT analysis (chi2 = 6.26, P= 0.006, chi2 = 9.00, P=0.001 when one affected offspring was selected at random from each family, suggesting that the results are due to association rather than linkage). There was no significant difference between the transmission of C102 from heterozygous fathers and mothers, which fails to support a role for genomic imprinting in this effect. T102C does not result in an alteration of the amino acid sequence of the protein. We therefore screened the promoter of 5HT2A for polymorphisms using single-strand confirmation polymorphism analysis. An A-G polymorphism at -1438 that creates an HpaII restriction site was identified. This was found to be in complete linkage disequilibrium with T102C and is hence a candidate for the pathogenic variant in schizophrenia. Functional analysis of A-1438G using luciferase assay demonstrated significant basal promoter activity in 5HT2A expressing HeLa cells by both the A and G variants. However, comparison of the A and G variants showed no significant differences in basal activity nor when promoter activity was induced by cAMP and protein kinase C-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491812     DOI: 10.1038/sj.mp.4000342

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  39 in total

Review 1.  Candidate-gene association studies of schizophrenia.

Authors:  M C O'Donovan; M J Owen
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  Genetic analyses of schizophrenia.

Authors:  C N Pato; K M Schindler; M T Pato
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

Review 3.  Recent advances in the genetics of schizophrenia.

Authors:  D M Waterwort; A S Bassett; L M Brzustowicz
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

Review 4.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 5.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

6.  Association of the 5-HT2A receptor gene polymorphism 102T/C with ischemic stroke.

Authors:  Ole F Olesen; Bente Bennike; Henrik Dam; Erling Mellerup
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 7.  Platelets and depression in cardiovascular disease: A brief review of the current literature.

Authors:  Marlene S Williams
Journal:  World J Psychiatry       Date:  2012-12-22

8.  Genetic association studies in psychiatry. Are we putting the cart before the horse?

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

9.  COMT but not serotonin-related genes modulates the influence of childhood abuse on anger traits.

Authors:  N Perroud; I Jaussent; S Guillaume; F Bellivier; P Baud; F Jollant; M Leboyer; C M Lewis; A Malafosse; P Courtet
Journal:  Genes Brain Behav       Date:  2009-10-23       Impact factor: 3.449

Review 10.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.